SCHEMBL4784069

SCHEMBL4784069

COC(=O)c1nc2ccccc2n1Cc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 0.60
CYP1A2 P05177 2/20 0.60
CYP2C9 P11712 2/20 0.60
LMNA P02545 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
TSPO P30536 2/20 0.57
TNF P01375 1/20 0.56
DRD2 P14416 6/20 0.56
TBXA2R P21731 6/20 0.56
POLB P06746 2/20 0.56
KDM4E B2RXH2 1/20 0.56
CFTR P13569 1/20 0.55
MAPT P10636 1/20 0.54
HKDC1 Q2TB90 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7085422 0.86 PLA2G2A (0.53) SMN1; SMN2TSPODRD2TBXA2RKDM4E
SCHEMBL4780057 0.84 CYP2C19 (0.60) CYP2C19CYP1A2CYP2C9LMNASMN1; SMN2
SCHEMBL28410934 0.83 CFTR (0.61) CYP2C19CYP1A2CYP2C9LMNASMN1; SMN2
SCHEMBL4728304 0.82 CYP1A2 (0.53) CYP2C19CYP1A2CYP2C9LMNASMN1; SMN2
SCHEMBL4784820 0.81 CYP2C19 (0.57) CYP2C19CYP1A2CYP2C9LMNASMN1; SMN2
SCHEMBL4784826 0.81 CYP2C19 (0.57) CYP2C19CYP1A2CYP2C9LMNASMN1; SMN2
SCHEMBL6553446 0.78 AR (0.51) CYP2C19CYP1A2CYP2C9SMN1; SMN2DRD2
SCHEMBL19156191 0.78 POLB (0.60) CYP2C19CYP1A2CYP2C9LMNASMN1; SMN2
SCHEMBL23997462 0.77 DRD2 (0.75) LMNADRD2TBXA2RCFTRMAPT
SCHEMBL30336823 0.77 DRD2 (0.75) LMNADRD2TBXA2RCFTRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008033739-A2 BENZIMIDAZOLE CARBOXAMIDE DERIVATIVES NEUROGEN CORPORATION (US) 2008-03-20 WO disclosed
WO-2008033739-A2 BENZIMIDAZOLE CARBOXAMIDE DERIVATIVES NEUROGEN CORPORATION (US) 2008-03-20 WO disclosed